Identification of a Novel Locus for Progressive Symmetric Erythrokeratodermia to a 19.02-Cm Interval at 21Q11.2–21q21.2
Yong Cui,Sen Yang,Min Gao,Wenming Zhou,Ming Li,Ying Wang,Jianjun Chen,Kai‐Lin Yan,Zhenmin Niu,Peiguang Wang,Feng‐Li Xiao,Yanhua Liang,Liangdan Sun,Xing Fan,Wei Huang,Xuejun Zhang
DOI: https://doi.org/10.1038/sj.jid.5700363
2006-01-01
Abstract:erythrokeratoderma erythrokeratodermia variabilis progressive symmetric erythrokeratodermia The erythrokeratodermas (EKs) include a clinically and genetically heterogeneous group of disorders characterized by erythematous and hyperkeratotic lesions, either stationary or migratory. Two major subtypes have been defined: erythrokeratodermia variabilis (EKV, OMIM 133200) and progressive symmetric erythrokeratodermia (PSEK, OMIM 602036). PSEK is characterized by fixed erythematous keratotic plaques distributing symmetrically over the body, particularly on the extremities, the buttocks, and the faces, sometimes together with palmoplantar keratoderma. Two sisters have been described, in which the younger one suffering EKV whereas the older one suffering PSEK, and this report brought forward the hypothesis that PSEK and EKV were different manifestations of a single conditions (MacFarlane et al., 1991MacFarlane A.W. Chapman S.J. Verbov J.L. Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings.Br J Dermatol. 1991; 124: 487-491Crossref PubMed Scopus (49) Google Scholar). However, accumulating genetic studies supported the distinct molecular pathology underlying them (Richard et al., 1998Richard G. Smith L.E. Bailey R.A. Itin P. Hohl D. Epstein Jr, E.H. et al.Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.Nat Genet. 1998; 20: 366-369Crossref PubMed Scopus (301) Google Scholar, Richard et al., 2002Richard G. Brown N. Smith L.E. Terrinoni A. Melino G. Mackie R.M. et al.The spectrum of mutations in erythrokeratodermias novel and de novo mutations in GJB3.Hum Genet. 2002; 106: 321-329Crossref Scopus (84) Google Scholar, Richard et al., 2003Richard G. Brown N. Rouan F. Van der Schroeff J.G. Bijlsma E. Eichenfield L.F. et al.Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype–phenotype correlations.J Invest Dermatol. 2003; 120: 601-609Crossref PubMed Scopus (110) Google Scholar). The major clinical feature distinguishing between PSEK and EKV is the sharply outlined geographical regions of migratory erythema in the latter (Ishida-Yamamoto et al., 1997Ishida-Yamamoto A. McGrath J.A. Lam H. Iizuka H. Friedman R.A. Christiano A.M. The molecular pathology of autosomal dominant erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope.Am J Hum Genet. 1997; 61: 581-589Abstract Full Text PDF PubMed Scopus (126) Google Scholar), and parakeratosis is an evident pathological feature in PSEK and usually not seen in EKV. Furthermore, ichthyotic variant of Vohwinkel syndrome, KID syndrome, and some transgradient forms of palmoplantar keratoderma should also be differentiated from PSEK based on the clinical and histological characteristics. The pathologic mechanism of PSEK is still unknown. No loci for PSEK have been defined by genetic linkage analysis up to date. A frameshift mutation (709insC) in the loricrin gene (OMIM #152445) on chromosome 1q21 has been identified in a Japanese PSEK family with generalized, well-demarcated erythematous hyperkeratotic plaques and mutilating palmoplantar keratoderma (pseudoainhum) (Ishida-Yamamoto et al., 1997Ishida-Yamamoto A. McGrath J.A. Lam H. Iizuka H. Friedman R.A. Christiano A.M. The molecular pathology of autosomal dominant erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope.Am J Hum Genet. 1997; 61: 581-589Abstract Full Text PDF PubMed Scopus (126) Google Scholar). Loricrin is a major structural component of the crosslinked cell envelope of the epidermis, which participates in the formation of keratohyalin granules (Hohl et al., 1991Hohl D. Mehrel T. Lichti U. Turner M.L. Roop D.R. Steinert P.M. Characterization of human loricrin: structure and function of a new class of epidermal cell envelope proteins.J Biol Chem. 1991; 266: 6626-6636Abstract Full Text PDF PubMed Google Scholar; Candi et al., 1995Candi E. Melino G. Mei G. Tarcsa E. Chung S.I. Marekov L.N. et al.Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein.J Biol Chem. 1995; 270: 26382-26390Crossref PubMed Scopus (152) Google Scholar), and the responsibility of the loricrin gene for variant form of Vohwinkel syndrome has been demonstrated (Maestrini et al., 1996Maestrini E. Monaco A.P. McGrath J.A. Ishida-Yamamoto A. Camisa C. Hovnanian A. et al.A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel syndrome.Nature Genet. 1996; 13: 70-77Crossref PubMed Scopus (213) Google Scholar). Some authors considered the Japanese pedigree mentioned above affecting variant form of Vohwinkel syndrome rather than PSEK, because pseudoainhum was usually not seen in PSEK, and the location of above mutation was only 21 bp upstream to that of Vohwinkel syndrome variant form (730insG) (Richard et al., 2002Richard G. Brown N. Smith L.E. Terrinoni A. Melino G. Mackie R.M. et al.The spectrum of mutations in erythrokeratodermias novel and de novo mutations in GJB3.Hum Genet. 2002; 106: 321-329Crossref Scopus (84) Google Scholar). Our previous study has excluded the loricrin gene is the responsibility gene for PSEK (Cui et al., 2004Cui Y. Yang S. He P.P. Zhou W.M. Li M. Gao M. et al.Progressive symmetric erythrokeratodermia: report of a Chinese family and evidence for genetic heterogeneity.J Dermatol Sci. 2004; 35: 233-235Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar). To map the disease locus of PSEK, we carried out a genome-wide scan in a five-generation Chinese PSEK family consisting of 27 individuals. There are 12 affected individuals in this family, including five males and seven females. Kindred examined exhibited the hallmarks of autosomal dominant inheritance with high penetrance. The proband (IV:5) was a 16-year-old female, her lesions developed when she was 3 years old and did not change much thereafter. Physical examination shows well-demarcated, slightly raised, hyperkeratotic erythematous plaques distributed on the dorsum of hands and feet symmetrically, accompany with obviously palmoplantar keratoderma. Clinical and histological features are showed in Figure 1a–c. All patients have typical features of the PSEK trait, with normal mucous membranes, nails, teeth, and hair. None patient shows pseudoainhum. This study was adherent to the Declaration of Helsinki Principles and approved by the medical ethical committee of the Anhui Medical University. After obtaining informed consent, 18 members of this family (nine affected and nine unaffected individuals) participated in this genetic study by donating 10 ml of blood for DNA extraction and genotyping analysis. Genomic DNAs were extracted from peripheral blood by use of a blood kit (Qiagen Inc., Hilden, Germany). We first undertook a genome-wide scan using 382 microsatellite markers from the ABI's Prism Linkage Mapping Set (Version 2). All the markers were genotyped in multiplex PCR following the guidelines from the manufacturer (Applied Biosystems, Foster City, CA). The results of two-point linkage analysis strongly suggest linkage at 21q11.2–21q21.2 with LOD scores of 2.82 at D21S1914 (θ=0.00). We then selected 12 additional microsatellite markers from David Duffy's interpolated map (http://www2.qimr.edu.au/davidD/), and the linkage results from these added markers confirmed our original finding by giving a maximum two-point LOD score of 4.33 at marker D21S1257 (θ=0.00). All the two-point LOD scores of the 13 markers analyzed in this study were summarized in Table 1.Table 1Two-point linkage analysis between PSEK and the markers at chromosome 21LOD score at θMarkersLocation (cM)0.000.100.200.300.40D21S19113.60-4.340.390.620.430.08D21S12345.831.641.250.840.440.13D21S1109.291.791.380.950.510.15D21S189913.600.120.06-0.01-0.05-0.04D21S190515.441.771.370.940.500.15D21S192217.922.181.751.290.790.28D21S188418.583.923.202.411.540.62D21S125721.794.333.532.671.710.69D21S189222.621.052.412.001.370.61D21S191423.302.822.291.701.070.42D21S26926.622.712.181.621.010.39D21S125828.71-1.060.630.580.400.09D21S191629.05-2.500.890.840.530.19LOD scores were calculated under an autosomal dominant mode of inheritance, a penetrance of 99.9% at various recombination fractions. Genetic coordinates in centimorgans according to David Duffy's interpolated map. Open table in a new tab LOD scores were calculated under an autosomal dominant mode of inheritance, a penetrance of 99.9% at various recombination fractions. Genetic coordinates in centimorgans according to David Duffy's interpolated map. To determine the smallest interval containing the PSEK locus, recombination events among the family members were analyzed by haplotype reconstruction (Figure 1d). Autosomal dominant inheritance with 99.9% penetrance was assumed. The affected allele frequency was taken as 0.0001. Marker allele frequencies were obtained from all individuals' genotyping data. The recombination frequency was assumed to be equal for both sexes. Two-point linkage analysis was performed using Linkage programs version 5.10, haplotypes were constructed with Cyrillic Version 2.02 software. The recombination events in individuals III:4, III:6, IV:2, IV:3, IV:4, IV:5, IV:7, and V:1 place the PSEK locus upper to D21S1911 and an affected members (IV:4) place the lower boundaries to D21S1892. These results suggest that the gene responsible for PSEK in this family lies in the 19.02 cM interval between D21S1911 and D21S1892. This interval spans about 9 Mb on the physical map. There are 23 genes within the critical regions, including 18 confirmed genes. Four known genes (NRIP1 (OMIM 602490), USP25 (OMIM604736), BTG3 (OMIM 605674), and CHODL (OMIM 607247)), whose transcripts had been isolated from skin cDNA libraries could be selected as candidate genes for further investigation. Ubiquitin, the encoded protein of USP25, is a highly conserved 76-amino-acid protein involved in the regulation of intracellular protein breakdown, cell cycle regulation, and stress response. BTG3 is a novel member of the PC3/BTG/TOB family of growth inhibitory genes. CHODL is a type I transmembrane protein homologous to C-type lectins, which characterized by calcium-dependent carbohydrate-binding activity and a common carbohydrate recognition domain. Keratin genes were considered to be good candidates because several hyperkeratotic cutaneous disorders are caused by mutations of keratins (Fuchs and Cleveland, 1998Fuchs E. Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease.Science. 1998; 279: 514-519Crossref PubMed Scopus (832) Google Scholar; Coulombe and Omary, 2002Coulombe P.A. Omary M.B. “Hard” and “soft” principles defining the structure, function and regulation of keratin intermediate filaments.Curr Opin Cell Biol. 2002; 14: 110-122Crossref PubMed Scopus (557) Google Scholar), but no known keratin gene was found in this locus. In conclusion, we identified a novel locus for PSEK on chromosome 21q11.2–21q21.2 in a Chinese family. It will aid future identification of the responsible gene, which will be useful for the understanding of the molecular mechanism of PSEK. This work was funded by grants from the Chinese High Tech Program (863) (2003AA227030) and the National Science Foundation of China (30500440). We are most grateful to the PSEK family for participating in this study. Mapview, http://www.ncbi.nlm.nih.gov/mapview/ Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/OMIM David Duffy's QIMR Homepage, http://www2.qimr.edu.au/davidD/